Zhenlei Zhang

发表

Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment Components.

Ming Jiang, Yong Chu, Tongfu Yang, 2021, Journal of medicinal chemistry.

Human serum albumin-based dual-agent delivery systems for combination therapy: acting against cancer cells and inhibiting neovascularization in the tumor microenvironment.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2020, Molecular pharmaceutics.

Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain.

Zhenlei Zhang, Hong Liang, Feng Yang, 2016, Molecular pharmaceutics.

Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2019, European journal of medicinal chemistry.

Current status of iridium-based complexes against lung cancer

Minghui Zhu, Ming Jiang, Tongfu Yang, 2022, Frontiers in Pharmacology.

Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2020, Journal of medicinal chemistry.

Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2016, European journal of medicinal chemistry.

Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2015, European journal of medicinal chemistry.

Novel Pt(ii) complexes with modified aroyl-hydrazone Schiff-base ligands: synthesis, cytotoxicity and action mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2019, Metallomics : integrated biometal science.

Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2018, European journal of medicinal chemistry.

Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2021, Journal of medicinal chemistry.

Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex.

Zhenlei Zhang, Hong Liang, Feng Yang, 2019, Metallomics : integrated biometal science.

A novel brain-tumor-inhibiting copper(II) compound based on a human serum albumin (HSA)-cell penetrating peptide conjugate.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2019, Journal of medicinal chemistry.

Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.

Zhenlei Zhang, Hong Liang, Feng Yang, 2017, Molecular pharmaceutics.

Synthesis of a series of novel In(III) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2020, Dalton transactions.

Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2017, Journal of inorganic biochemistry.

HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2018, Drug delivery.

Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer.

Ming Jiang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin.

Tongfu Yang, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin.

Wenjuan Li, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2017, Journal of inorganic biochemistry.

Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.

Zhenlei Zhang, Hong Liang, Feng Yang, 2017, Molecular pharmaceutics.

Thiosemicarbazone Mixed-Valence Cu(I/II) Complex against Lung Adenocarcinoma Cells through Multiple Pathways Involving Cuproptosis.

Zhenlei Zhang, Y. Gou, Kai Huang, 2024, Journal of medicinal chemistry.

Developing a Hetero-Trinuclear Erbium(III)-Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor Microenvironment.

Zhenlei Zhang, Hong Liang, Minghui Zhu, 2023, Molecular pharmaceutics.

A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death

Wenjuan Li, Zhenlei Zhang, Shanhe Li, 2024, Rare Metals.

Rational Design of a Hetero-multinuclear Gadolinium(III)-Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer.

Wenjuan Li, Zhenlei Zhang, Shanhe Li, 2024, Journal of medicinal chemistry.

Novel 3‐Substituted Ocotillol‐Type Triterpenoid Derivatives as Antibacterial Candidates

Jian Yang, Zhenlei Zhang, Jinyi Xu, 2014, Chemical biology & drug design.